Literature DB >> 22864558

Lack of anti-drug antibodies in patients with psoriasis well-controlled on long-term treatment with tumour necrosis factor inhibitors.

Martin W Meyer1, Claus Zachariae, Klaus Bendtzen, Lone Skov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22864558     DOI： 10.2340/00015555-1376

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  4 in total

1.  Positive correlation between etanercept concentration and the decrease in Psoriasis Area and Severity Index scale value.

Authors:  Laida Elberdín; Maria Outeda; Pilar Salvador; Sabela Paradela; Rosa María Fernández-Torres; Raquel Iglesias; Eduardo Fonseca; Isabel Martín
Journal:  Int J Clin Pharm       Date:  2016-07-19

Review 2.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

3.  Infliximab drug and antibody levels in patients with dermatological conditions.

Authors:  L Elberdín; M Outeda; P Salvador; S Paradela; R M Fernández-Torres; R Iglesias; E Fonseca; I Martín
Journal:  Int J Clin Pharm       Date:  2015-01-23

Review 4.  Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab.

Authors:  B Gorovits; D J Baltrukonis; I Bhattacharya; M A Birchler; D Finco; D Sikkema; M S Vincent; S Lula; L Marshall; T P Hickling
Journal:  Clin Exp Immunol       Date:  2018-03-30       Impact factor: 4.330
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.